HOME > ABOUT

COMPANY PROFILE

  • 2013

    Establishment

  • USD 1.3

    Billion

  • 180 +

    Portfolio Companies

  • Top10

    Healthcare VCs

Yuanbio Venture Capital is a leading healthcare investment firm focusing on early and growth stage investment opportunities. Headquartered in Suzhou bioBay, we look for highly innovative companies across the country and keeps a global view on the development of healthcare industry. Till now, there are over 180 companies in our investment portfolio, covering biotech, medical devices, IVD and healthcare services, and 19 of the companies are listed on the SRAT Board, HKEX and Nasdaq, delivering outstanding performance to our funds. YuanBio has been awarded as one of the top healthcare VCs in China for many consecutive years. Our team consists of experts with rich experiences in healthcare industry, business management and early-stage investment. With passion, dedication and expertise, YuanBio strives to become one of the most successful healthcare venture capital firms in China.

STRENGTHS & CAPABILITIES

AWARDS & HONORS

投中榜 2015年度中国新锐创业投资机构TOP10
2016年精准医疗创新论坛暨第六届中国医健创新创业大会之年度最新锐投资机构
2016生命科学领域“最耀眼”的十大投资机构之一

PARTNERS

BioBay

Located in Dushu Lake Science and Education Innovation Zone, BioBay covers 86.3 hectares and 1 million floor area. It is the vehicle for biotech and nanotech innovation of the Suzhou Industrial Park. China Academy of Science' s NanoTech Research Institute is also located in BioBay. Since its inception in June 2007, BioBay has received many titles and awards, including CXO Model Park, Innovation and Entrepreneurship Hub for High Level Overseas Educated Talents . Jiangsu Provincial BioPharma Industry Park, Jiangsu Provincial 5-Star Service Platform for Middle and Small Enterprises etc. It is also recognized as National-level High-Tech Enterprise Incubator. National-level Torch Plan Industry Base and National-level NanoTech University Technology Park. Now Biobay has become the core area of National NanoTech International Innovation Zone.

Jiangsu Feixiang Group

Jiangsu Feixiang Chemical Group ("Feixiang Group") was founded in 1970. After 40 years of unremitting efforts and strategic development, Feixiang Group has become one of the leading companies in China's fine chemistry industry. Headquatered in the Suzhou Industrial Park, it has over 10 subsidiaries and the group sales in 2011 reached CNY 6.5 billion. Feixiang Group has four business sectors: inorganic materials, monomeric and water soluble high molecular, fine organic chemicals and polycompounds and engineering plastic. It has established chemical manufacturing base with world-class manufacturing capacity in Jiangsu Binhai, Zhangjiagang Phoenix, Zhangjiagang Yangtze River Chemical Park and Lianyungang Donghai.
Feixiang Group has been paying attention to the technology research and development for sustainable development on a longterm basis. In the past 10 years, Feixiang Group has built several scientific and technological innovation platform, including national post-doctoral work station, Jiangsu provincial engineerting technology research center, Dalian Shimu Chemical and Feixiang New Materials Research Institute. Meanwhile, it has jointly developed a number of R&D projects with domestic renowned universities, research institutes and global clients.

Sungent Holding Group

Sungent Holding Group is a large-scale state-owned enterprise within the Suzhou Industrial Park (SIP), and a joint project between China and Singapore. Sungent has over 80 different share holding companies, with assets of over 32 billion RMB. The Group is one of the largest comprehensive real estate developers in Jiangsu Province.
Sungent will assume responsibility to create value for the city, lead industrial innovation, and promote transformation and modernization. The Group is determined to be a leader in quality living by working to fulfill dreams and improving life.

CreditEase

CreditEase is a renowned wealth management firm in China. Headquartered in Beijing, it has over 1000 senior wealth management consultants in more than 40 cities and serves over 200,000 high net-worth individuals.
CreditEase offers tailored financial planning based on clients' financial needs, taking their risk profile, financial status and family structure into consideration. It brings well performed fixed income, private equity, capital markets, overseas asset management, public welfare wealth management and other types of financial planning approaches and products to thousands of clients through scientific asset allocation, so as to satisfy people's requirements at different life stages.
CreditEase endeavors to become the long-term trusted wealth management partner of the general public and brings honesty, professionalism and innovative services to every client and family.